Biocell
10 papers11 directions
Biocell is a research venue active from 2021 to 2025 that focuses on the intersection of molecular biology, neuroscience, and therapeutic development. Its publications cover a range of topics including the mechanisms of ischemic stroke, glial homeostatic regulation, and the dynamics of brain connectivity. The venue serves as a platform for studies involving precision therapeutics, such as subunit-selective receptor modulation and nanoscale delivery systems for bioactive compounds.
Research at Biocell frequently utilizes computational and data-driven approaches to address complex biological questions. This includes the use of comparative transcriptomics to identify phenotypic drivers and the development of predictive models, such as the lactylation index for assessing immune microenvironments and prognosis in pan-cancer studies. The venue also explores the longitudinal dynamics of functional and structural connectivity, reflecting an interest in high-dimensional data analysis within the neural and biological sciences.
In the context of machine learning and artificial intelligence, Biocell contributes to the application of these technologies in precision medicine and oncology. It publishes work on molecular regulators for tissue homeostasis and the oncogenic potential of genetic variants. Prolific contributors to the venue include researchers such as Hong Liao, Chaoran Wu, and M.I. Airapetov, whose work spans areas from neuroinflammation and chronic stress trajectories to the therapeutic potential of CAR T cells.
Papers by Year
| 2025 | 3 |
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 2 |
| 2021 | 2 |
Top Research Directions
Research directions most represented by papers from this venue.